“Positive predictive value refers to the percentage of patients with a positive test for a disease who actually have the disease. The negative predictive value of a test is the proportion of patients with negative test results who do not have the disorder.
The percentage of patients with a disorder who have a positive test for that disorder is a test’s sensitivity. The percentage of patients without a disorder who have a negative test for that disorder is a test’s specificity.”
BIOSTATISTICS
The AFP EBM Glossary.
The ideal confirmation test will have both high sensitivity and high specificity.
Having a positive or negative test isn’t final. A positive or negative predictive value predicts the likelihood that your test result is actually true.
—\\\—
Note: Risk=Probability
Attributable risk:
Standard deviation:
Skewed distribution:
Test reliability:
Test validity:
Correlation Coefficient:
Confidence Interval:
Comparison of data
- “Chi-squared test: Used to compare percentages or proportions (nonnumerical or nominal data)
- T-test: Used to compare two means
- Analysis of variance (ANOVA): Used to compare three or more means.” From Crush Step 3
Incidence: (New cases of a disease) ÷ ( population at risk) in a given period of time
Prevalence: (Total cases of disease) ÷ ( population). It can be at a single point in time (“ point prevalence”) or over a period of time (“ period prevalence”)
The number needed to treat/ harm: # of pts that must be treated to prevent/ cause 1 pt to have the measured outcome; 1/( risk difference), e.g., 1/( 0.1) → NNT of 10
TYPES OF STUDIES IN EPIDEMIOLOGY
Types of studies in epidemiology.
References:
- Leon Gordis, Epidemiology, 5th Edition.
- Pocket Primary Care
- Adam Brochert, Crush Step 3
- http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1706071/
- http://www.aafp.org/fpm/2004/0500/p47.html (A Simple Method for Evaluating the Clinical Literature)
- https://onlinecourses.science.psu.edu/stat507/node/71 (Sensitivity, Specificity, Positive Predictive Value, and Negative Predictive Value)
- http://handbook.cochrane.org/chapter_9/9_2_2_4_measure_of_absolute_effect_the_risk_difference.htm
- http://childhoodcancer.cochrane.org/non-randomised-controlled-study-nrs-designs
- Goldman L, Schafer AI (eds): Goldman’s Cecil Medicine, ed 25. Elsevier Saunders, 2016, pp 37-41.